Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-21-013036

Chief Medical Officer bought 1,670 shares at $4.81 ($8,033)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Levy Howard Chief Medical Officer 2021-02-09 Purchase +1,670 $4.81 $8,033 23,390 I
Open-market purchases · 1,670 sh · avg $4.81 · $8,033
Loading xslF345X03/doc4.xml…